Ayman Grada

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Atopic Dermatitis

Top Venues

Antibiotics (Basel, Switzerland)

American journal of clinical dermatology

Dermatologic therapy

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Maria K Armillei, Ivan B Lomakin, James Q Del Rosso, Ayman Grada, Christopher G Bunick
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Maria K Armillei, Ivan B Lomakin, James Q Del Rosso, Ayman Grada, Christopher G Bunick
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Maria K Armillei, Ivan B Lomakin, James Q Del Rosso, Ayman Grada, Christopher G Bunick
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Maria K Armillei, Ivan B Lomakin, James Q Del Rosso, Ayman Grada, Christopher G Bunick
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Faraz Yousefian, Roksana Hesari, Taylor Jensen, Sabine Obagi, Ala Rgeai, Giovanni Damiani, Christopher G Bunick, Ayman Grada
Antimicrobial Wound Dressings: A Concise Review for Clinicians. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Ivan B Lomakin, Swapnil C Devarkar, Shivali Patel, Ayman Grada, Christopher G Bunick
Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. Nucleic acids research (2023)
Patrick O Perche, Gabrielle M Peck, Lillian Robinson, Ayman Grada, Alan B Fleischer, Steven Richard Feldman
Prescribing Trends for Acne Vulgaris Visits in the United States. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Rachel E Tao, Stuti Prajapati, Jessica N Pixley, Ayman Grada, Steven Richard Feldman
Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. Antibiotics (Basel, Switzerland) 12 (7) (2023)
Patrick O Perche, Gabrielle M Peck, Lillian Robinson, Ayman Grada, Alan B Fleischer, Steven Richard Feldman
Prescribing Trends for Acne Vulgaris Visits in the United States. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Patrick O Perche, Gabrielle M Peck, Lillian Robinson, Ayman Grada, Alan B Fleischer, Steven Richard Feldman
Prescribing Trends for Acne Vulgaris Visits in the United States. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Ayman Grada, Mahmoud A Ghannoum, Christopher G Bunick
Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Todd Schlesinger, Eggert Stockfleth, Ayman Grada, Brian Berman
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. Clinical, cosmetic and investigational dermatology 15 (2022)
Mahmoud A Ghannoum, Lisa Long, Christopher G Bunick, James Q Del Rosso, Ahmed Gamal, Stephen K Tyring, Thomas S McCormick, Ayman Grada
Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota. Antibiotics (Basel, Switzerland) 11 (3) (2022)
Alessandra Buja, Andrea Miatton, Claudia Cozzolino, Lorenzo Monasta, Ayman Grada, Chante Aksut Karimkhani, Mohsen Naghavi, Giovanni Damiani
The global, regional, and national burden of seborrheic dermatitis: results and insights from the Global Burden of Disease 2019 Study. Archives of dermatological research (2022)
Alessia Pacifico, Paolo D M Pigatto, Antonio Cristaudo, Diego Orsini, null null, Alessandra Buja, Dennis Linder, Ayman Grada, Giovanni Damiani
RNA-based COVID-19 vaccine is not a contraindication to phototherapy: Real-life data on minimal erythema dose changes. Dermatologic therapy 35 (4) (2022)
Giovanni Damiani, Laura Cristina Gironi, Ayman Grada, Khalaf Kridin, Renata Finelli, Alessandra Buja, Nicola L Bragazzi, Paolo D M Pigatto, Paola Savoia
COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study. Dermatologic therapy 34 (2) (2021)
Ayman Grada, Steven R Feldman, Nicola Luigi Bragazzi, Giovanni Damiani
Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review. Dermatologic therapy 34 (2) (2021)
Christopher G Bunick, Jonette Keri, S Ken Tanaka, Nika Furey, Giovanni Damiani, Jodi L Johnson, Ayman Grada
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation. Antibiotics (Basel, Switzerland) 10 (4) (2021)
Ayman Grada, James Q Del Rosso, Emmy Graber, Christopher G Bunick, Linda Stein Gold, Angela Y Moore, Hilary Baldwin, Zaidal Obagi, Giovanni Damiani, Timothy Carrothers, Brian McNamee, Eva Hanze
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy. Dermatologic therapy 35 (3) (2021)
Alessia Pacifico, Rosalynn R Z Conic, Antonio Cristaudo, Sergio Garbarino, Marco Ardigò, Aldo Morrone, Paolo Iacovelli, Sara di Gregorio, Paolo Daniele Maria Pigatto, Ayman Grada, Steven Richard Feldman, Egeria Scoditti, Khalaf Kridin, Giovanni Damiani
Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study. Nutrients 13 (9) (2021)
Alanna C Bridgman, Christina Fitzmaurice, Robert P Dellavalle, Chante Karimkhani Aksut, Ayman Grada, Mohsen Naghavi, Navid Manafi, Andrew T Olagunju, Tinuke O Olagunju, Ranjani Somayaji, Aaron M Drucker
Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study [Formula: see text]. Journal of cutaneous medicine and surgery 24 (2) (2020)
Angela Yen Moore, James Q Del Rosso, Jodi L Johnson, Ayman Grada
Sarecycline: A Review of Preclinical and Clinical Evidence. Clinical, cosmetic and investigational dermatology 13 (2020)
Giovanni Damiani, Alessia Pacifico, Dennis M Linder, Paolo D M Pigatto, Rosalynn Conic, Ayman Grada, Nicola L Bragazzi
Nanodermatology-based solutions for psoriasis: State-of-the art and future prospects. Dermatologic therapy 32 (6) (2019)
Ayman Grada, Vincent Falanga
Cryofibrinogenemia-Induced Cutaneous Ulcers: A Review and Diagnostic Criteria. American journal of clinical dermatology 18 (1) (2017)